GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Shyndec Pharmaceutical Co Ltd (SHSE:600420) » Definitions » Cash Flow from Discontinued Operations

Shanghai Shyndec Pharmaceutical Co (SHSE:600420) Cash Flow from Discontinued Operations : ¥0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Shanghai Shyndec Pharmaceutical Co Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Shanghai Shyndec Pharmaceutical Co's cash flow from discontinued operations for the three months ended in Mar. 2025 was ¥0 Mil. It means Shanghai Shyndec Pharmaceutical Co received ¥0 Mil from the sale of part of business quarterly. Shanghai Shyndec Pharmaceutical Co's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0 Mil.


Shanghai Shyndec Pharmaceutical Co Cash Flow from Discontinued Operations Historical Data

The historical data trend for Shanghai Shyndec Pharmaceutical Co's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Shyndec Pharmaceutical Co Cash Flow from Discontinued Operations Chart

Shanghai Shyndec Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Shanghai Shyndec Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Shanghai Shyndec Pharmaceutical Co Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Shyndec Pharmaceutical Co Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Shanghai Shyndec Pharmaceutical Co's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Shyndec Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.1320 Beijinxi Road, Shanghai, CHN, 200040
Shanghai Shyndec Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical preparations, biological pharmaceuticals, chemical raw materials, and Chinese medicine formulations in China and internationally. It provides biological and chemical raw material medicines, microbial fermentation products and tablets, capsules, granules, injections, suspensions, and suppositories, as well as ointments, including product formulations.
Executives
Li Hao senior management
Ni Feng Director
Li Xian Lin senior management
Hao Chao Feng senior management
Lian Wan Yong Director
Han Yan Lin Director
Yang Wen Ming Supervisors
Feng Ming Director

Shanghai Shyndec Pharmaceutical Co Headlines

No Headlines